BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2668623)

  • 1. [Pulsatory secretion of pancreatic hormones].
    Lefèbvre P; Paolisso G; Scheen A
    Journ Annu Diabetol Hotel Dieu; 1989; ():37-46. PubMed ID: 2668623
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxytocin increases arginine-induced A and B cell secretion in normal man and in diabetic subjects.
    Paolisso G; Sgambato S; Passariello N; Giugliano D; Torella R; Memoli P; Varricchio M; D'Onofrio F
    Diabete Metab; 1988; 14(2):104-7. PubMed ID: 3042483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very short-term effects of the dipeptidyl peptidase-4 inhibitor sitagliptin on the secretion of insulin, glucagon, and incretin hormones in Japanese patients with type 2 diabetes mellitus: analysis of meal tolerance test data.
    Murai K; Katsuno T; Miyagawa J; Matsuo T; Ochi F; Tokuda M; Kusunoki Y; Miuchi M; Namba M
    Drugs R D; 2014 Dec; 14(4):301-8. PubMed ID: 25420579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
    Hare KJ
    Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin therapy in insulin-dependent (type I) diabetes mellitus.
    Nolte MS
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):281-312. PubMed ID: 1612067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin and its place in the therapy of diabetes mellitus types 1 and 2].
    Balabolkin MI
    Probl Endokrinol (Mosk); 1990; 36(4):63-9. PubMed ID: 2235935
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of glucagon in the endogenous hyperglycemia of diabetes mellitus.
    Unger RH; Orci L
    Annu Rev Med; 1977; 28():119-30. PubMed ID: 324351
    [No Abstract]   [Full Text] [Related]  

  • 10. Albiglutide does not impair the counter-regulatory hormone response to hypoglycaemia: a randomized, double-blind, placebo-controlled, stepped glucose clamp study in subjects with type 2 diabetes mellitus.
    Hompesch M; Jones-Leone A; Carr MC; Matthews J; Zhi H; Young M; Morrow L; Reinhardt RR
    Diabetes Obes Metab; 2015 Jan; 17(1):82-90. PubMed ID: 25263215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enteroinsular axis revisited. A novel role for an incretin.
    Ensinck JW; D'Alessio DA
    N Engl J Med; 1992 May; 326(20):1352-3. PubMed ID: 1565148
    [No Abstract]   [Full Text] [Related]  

  • 12. Embracing insulin. It's a miracle drug. So why do so many people with type 2 try to avoid the needle at any cost?
    Gebel E
    Diabetes Forecast; 2008 Aug; 61(8):45-7. PubMed ID: 18788128
    [No Abstract]   [Full Text] [Related]  

  • 13. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
    Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
    N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of exogenous hyperglucagonemia in insulin-treated diabetics.
    Raskin P; Unger RH
    Diabetes; 1977 Nov; 26(11):1034-9. PubMed ID: 410690
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
    Christensen MB
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new long-acting insulin analog. "Fewer hypoglycemias observed"].
    Gallwitz B
    MMW Fortschr Med; 2004 Jan; 146(3-4):47. PubMed ID: 15035450
    [No Abstract]   [Full Text] [Related]  

  • 18. [From insulin secretion to insulin therapy].
    Soltani D; Perlemuter L
    Presse Med; 1998 Jul 4-11; 27(24):1240-6. PubMed ID: 9767787
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin levels after injection by jet stream and disposable syringe.
    Lucas A; Ribas L; Salinas I; Audí L; Sanmartí A; Foz M
    Diabetes Care; 1988 Mar; 11(3):298-9. PubMed ID: 3046856
    [No Abstract]   [Full Text] [Related]  

  • 20. The interaction of insulin and glucagon on the liver.
    Rastogi GK
    J Assoc Physicians India; 1972 Nov; 20(11):859-66. PubMed ID: 4654918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.